Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Personalized Alternative Non-invasive Rapid Diagnostic Test for SARS-CoV-2 in Patients With Long COVID

NCT07343856 is registered in ClinicalTrials.gov with Oncology Center,Ministry Of Heath,Uzbekistan as lead sponsor.

NCT NCT07343856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07343856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Personalized Alternative Non-invasive Rapid Diagnostic Test for SARS-CoV-2 in Patients With Long COVID
Lead sponsor
Oncology Center,Ministry Of Heath,Uzbekistan
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
December 5, 2025
Completion date
January 1, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long covid, post-acute sequelae of sars-cov-2 infection